| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
OMI Stock Overview
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally.
Owens & Minor Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$45.32 |
| 52 Week High | US$49.16 |
| 52 Week Low | US$23.58 |
| Beta | 0.33 |
| 1 Month Change | 7.24% |
| 3 Month Change | 28.57% |
| 1 Year Change | 66.80% |
| 3 Year Change | 510.78% |
| 5 Year Change | 23.62% |
| Change since IPO | 1,076.58% |
Recent News & Updates
With EPS Growth And More, Owens & Minor (NYSE:OMI) Is Interesting
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Owens & Minor: Pandemic Winner Has More Upside In 2022
OMI, as a leading PPE manufacturer, has generated strong growth during the pandemic with higher earnings. The latest surge of Omicron Covid cases worldwide likely supports an incremental boost to the business with upside to estimates into the current quarter. We like the stock as a leading medical solutions provider which benefits from solid fundamentals and a positive long-term outlook.
Shareholder Returns
| OMI | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -4.2% | -3.3% | -4.6% |
| 1Y | 66.8% | 12.7% | 7.7% |
Return vs Industry: OMI exceeded the US Healthcare industry which returned 13.9% over the past year.
Return vs Market: OMI exceeded the US Market which returned 10.2% over the past year.
Price Volatility
| OMI volatility | |
|---|---|
| OMI Average Weekly Movement | 7.9% |
| Healthcare Industry Average Movement | 7.9% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 2.4% |
Stable Share Price: OMI is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: OMI's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1882 | 18,800 | Ed Pesicka | https://www.owens-minor.com |
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.
Owens & Minor Fundamentals Summary
| OMI fundamental statistics | |
|---|---|
| Market Cap | US$3.42b |
| Earnings (TTM) | US$230.36m |
| Revenue (TTM) | US$9.68b |
14.8x
P/E Ratio0.4x
P/S RatioIs OMI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OMI income statement (TTM) | |
|---|---|
| Revenue | US$9.68b |
| Cost of Revenue | US$8.11b |
| Gross Profit | US$1.57b |
| Expenses | US$1.34b |
| Earnings | US$230.36m |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.05 |
| Gross Margin | 16.22% |
| Net Profit Margin | 2.38% |
| Debt/Equity Ratio | 106.6% |
How did OMI perform over the long term?
See historical performance and comparisonDividends
0.02%
Current Dividend Yield0.313%
Payout RatioValuation
Is Owens & Minor undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: OMI ($45.32) is trading below our estimate of fair value ($107.06)
Significantly Below Fair Value: OMI is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: OMI is good value based on its PE Ratio (14.8x) compared to the US Healthcare industry average (21.1x).
PE vs Market: OMI is good value based on its PE Ratio (14.8x) compared to the US market (17x).
Price to Earnings Growth Ratio
PEG Ratio: OMI is poor value based on its PEG Ratio (3.2x)
Price to Book Ratio
PB vs Industry: OMI is overvalued based on its PB Ratio (3.9x) compared to the US Healthcare industry average (2.6x).
Future Growth
How is Owens & Minor forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
4.7%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OMI's forecast earnings growth (4.7% per year) is above the savings rate (2%).
Earnings vs Market: OMI's earnings (4.7% per year) are forecast to grow slower than the US market (13% per year).
High Growth Earnings: OMI's earnings are forecast to grow, but not significantly.
Revenue vs Market: OMI's revenue (3.5% per year) is forecast to grow slower than the US market (9.2% per year).
High Growth Revenue: OMI's revenue (3.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: OMI's Return on Equity is forecast to be high in 3 years time (22.5%)
Past Performance
How has Owens & Minor performed over the past 5 years?
7.7%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: OMI has a large one-off loss of $75.2M impacting its September 30 2021 financial results.
Growing Profit Margin: OMI's current net profit margins (2.4%) are higher than last year (0.4%).
Past Earnings Growth Analysis
Earnings Trend: OMI's earnings have grown by 7.7% per year over the past 5 years.
Accelerating Growth: OMI's earnings growth over the past year (620.3%) exceeds its 5-year average (7.7% per year).
Earnings vs Industry: OMI earnings growth over the past year (620.3%) exceeded the Healthcare industry 32.5%.
Return on Equity
High ROE: Whilst OMI's Return on Equity (25.97%) is high, this metric is skewed due to their high level of debt.
Financial Health
How is Owens & Minor's financial position?
Financial Position Analysis
Short Term Liabilities: OMI's short term assets ($2.4B) exceed its short term liabilities ($1.4B).
Long Term Liabilities: OMI's short term assets ($2.4B) exceed its long term liabilities ($1.3B).
Debt to Equity History and Analysis
Debt Level: OMI's net debt to equity ratio (102.1%) is considered high.
Reducing Debt: OMI's debt to equity ratio has increased from 57.4% to 106.6% over the past 5 years.
Debt Coverage: OMI's debt is not well covered by operating cash flow (15.3%).
Interest Coverage: OMI's interest payments on its debt are well covered by EBIT (8.2x coverage).
Balance Sheet
Dividend
What is Owens & Minor current dividend yield, its reliability and sustainability?
0.022%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: OMI's dividend (0.022%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.35%).
High Dividend: OMI's dividend (0.022%) is low compared to the top 25% of dividend payers in the US market (3.48%).
Stability and Growth of Payments
Stable Dividend: OMI is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: OMI is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: OMI is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of OMI's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
3.0yrs
Average management tenure
CEO
Ed Pesicka (53 yo)
2.83yrs
Tenure
US$7,628,179
Compensation
Mr. Edward A. Pesicka, also known as Ed, has been the Chief Executive Officer, President and Director of Owens & Minor, Inc. since March 7, 2019. Mr. Pesicka served as Chief Commercial Officer of Thermo Fi...
CEO Compensation Analysis
Compensation vs Market: Ed's total compensation ($USD7.63M) is above average for companies of similar size in the US market ($USD5.14M).
Compensation vs Earnings: Ed's compensation has increased by more than 20% in the past year.
Leadership Team
Experienced Management: OMI's management team is considered experienced (3 years average tenure).
Board Members
Experienced Board: OMI's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.6%.
Top Shareholders
Company Information
Owens & Minor, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Owens & Minor, Inc.
- Ticker: OMI
- Exchange: NYSE
- Founded: 1882
- Industry: Health Care Distributors
- Sector: Healthcare
- Implied Market Cap: US$3.420b
- Shares outstanding: 75.46m
- Website: https://www.owens-minor.com
Number of Employees
Location
- Owens & Minor, Inc.
- 9120 Lockwood Boulevard
- Mechanicsville
- Virginia
- 23116-7626
- United States
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/01/19 23:34 |
| End of Day Share Price | 2022/01/19 00:00 |
| Earnings | 2021/09/30 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.